Signaturefd LLC Sells 336 Shares of Cognex Co. (NASDAQ:CGNX)

Signaturefd LLC lowered its stake in shares of Cognex Co. (NASDAQ:CGNX) by 19.7% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 1,368 shares of the scientific and technical instruments company’s stock after selling 336 shares during the period. Signaturefd LLC’s holdings in Cognex were worth $55,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. HHM Wealth Advisors LLC grew its holdings in Cognex by 19.8% during the second quarter. HHM Wealth Advisors LLC now owns 1,819 shares of the scientific and technical instruments company’s stock worth $85,000 after buying an additional 301 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Cognex by 11.3% in the second quarter. Fifth Third Bancorp now owns 3,829 shares of the scientific and technical instruments company’s stock valued at $179,000 after purchasing an additional 390 shares during the last quarter. Covestor Ltd lifted its position in shares of Cognex by 18.7% during the first quarter. Covestor Ltd now owns 2,977 shares of the scientific and technical instruments company’s stock valued at $126,000 after purchasing an additional 469 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in Cognex by 3.6% during the first quarter. Commonwealth Equity Services LLC now owns 13,871 shares of the scientific and technical instruments company’s stock worth $588,000 after purchasing an additional 487 shares during the last quarter. Finally, Creative Planning grew its position in Cognex by 2.4% in the 3rd quarter. Creative Planning now owns 21,919 shares of the scientific and technical instruments company’s stock worth $888,000 after purchasing an additional 512 shares in the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Dianne M. Parrotte acquired 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The shares were acquired at an average price of $38.62 per share, with a total value of $77,240.00. Following the acquisition, the director now owns 11,340 shares of the company’s stock, valued at approximately $437,950.80. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CFO Dennis Fehr acquired 6,570 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The shares were acquired at an average price of $38.04 per share, with a total value of $249,922.80. Following the acquisition, the chief financial officer now owns 6,570 shares of the company’s stock, valued at approximately $249,922.80. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Dianne M. Parrotte purchased 2,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was acquired at an average cost of $38.62 per share, for a total transaction of $77,240.00. Following the acquisition, the director now owns 11,340 shares in the company, valued at approximately $437,950.80. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have commented on CGNX shares. The Goldman Sachs Group dropped their target price on shares of Cognex from $45.00 to $39.00 and set a “sell” rating on the stock in a research report on Friday, August 2nd. StockNews.com upgraded Cognex from a “sell” rating to a “hold” rating in a research note on Friday, August 9th. Vertical Research initiated coverage on Cognex in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $58.00 price objective for the company. Robert W. Baird reduced their price objective on Cognex from $46.00 to $42.00 and set a “neutral” rating for the company in a research note on Monday, August 5th. Finally, Stephens upgraded Cognex from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $45.00 to $55.00 in a research note on Wednesday, October 16th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $50.00.

Cognex Price Performance

Shares of NASDAQ CGNX opened at $40.60 on Wednesday. Cognex Co. has a one year low of $34.28 and a one year high of $53.13. The business’s fifty day moving average price is $39.31 and its 200-day moving average price is $42.94. The stock has a market capitalization of $6.97 billion, a PE ratio of 70.00 and a beta of 1.41.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Wednesday, July 31st. The scientific and technical instruments company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.03. The business had revenue of $239.00 million for the quarter, compared to analysts’ expectations of $240.33 million. Cognex had a return on equity of 4.97% and a net margin of 9.29%. The firm’s quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.32 EPS. As a group, equities analysts expect that Cognex Co. will post 0.44 EPS for the current fiscal year.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.